3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
2
Status
Unknown
1
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Gastrointestinal
2
Breast
2
Gynecologic
1
Genitourinary
1
Conditions
Carcinoma, Non-Small-Cell Lung
7
Breast Neoplasms
6
Lung Neoplasms
5
Ovarian Neoplasms
4
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Urinary Bladder Neoplasms
2
Prostatic Neoplasms
2
Neoplasms
2
Inflammation
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thrombosis
1
Thromboembolism
1
Stomach Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Rectal Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Lymphoma
1
KRAS Mutant Non-Small Cell Lung Cancer
1
Immune System Diseases
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Interventions
palbociclib
2
cytisine
1
Spirometry
1
Rivaroxaban
1
Hematologic Tests
1
Exercise
1
Diet Therapy
1
Bevacizumab
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Inflammation
×
palbociclib
×
Thoracic
×
Clear all
NCT06307249
2024-03-12
PTST_PALBEVA
Lebanese University
Phase 1
Recruiting
50 enrolled
NCT06065592
2023-10-06
CAT_PB
Lebanese University
Phase 1
Unknown
500 enrolled